SCHEMBL1122632

SCHEMBL1122632

COC(=O)[C@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)c1ccc(OCCOc2ccccn2)cc1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.63
RAB9A P51151 1/20 0.63
PPARG P37231 2/20 0.56
GPR132 Q9UNW8 4/20 0.56
ERAP2 Q6P179 2/20 0.54
LNPEP Q9UIQ6 1/20 0.54
YAP1 P46937 2/20 0.49
PTPN1 P18031 1/20 0.49
IL1RN P18510 1/20 0.49
ERAP1 Q9NZ08 1/20 0.49
GABRA5 P31644 1/20 0.49
LTA4H P09960 1/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
GLA P06280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123333 0.91 GPR132 (0.67) PPARGGPR132PTPN1ITGB3ITGA2B
SCHEMBL1123055 0.88 GAA (0.80) GAARAB9APPARGGPR132ERAP2
SCHEMBL1123019 0.88 GAA (0.62) GAARAB9APPARGGPR132ERAP2
SCHEMBL1122610 0.86 RAB9A (0.74) GAARAB9APPARGGPR132ERAP2
SCHEMBL27638047 0.86 RAB9A (0.74) GAARAB9APPARGGPR132ERAP2
SCHEMBL1123147 0.86 GAA (0.71) GAARAB9APPARGGPR132ERAP2
SCHEMBL1122748 0.85 GAA (0.59) GAARAB9APPARGGPR132ERAP2
SCHEMBL1122645 0.85 GAA (0.69) GAARAB9APPARGGPR132ERAP2
SCHEMBL27658965 0.85 GAA (0.69) GAARAB9APPARGGPR132ERAP2
SCHEMBL1122834 0.85 GAA (0.75) GAARAB9APPARGGPR132ERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP claimed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US claimed
EP-1644321-A2 NEW BENZAMIDES AS PPATY MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-04-12 EP claimed
WO-2004110983-A2 NEW BENZAMIDES AS PPARϒ MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2004-12-23 WO claimed
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed
EP-1644321-A2 NEW BENZAMIDES AS PPATY MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2006-04-12 EP disclosed
WO-2004110983-A2 NEW BENZAMIDES AS PPARϒ MODULATORS LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG GAA 3048/4885RAB9A 4567/4885PPARG 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.